建立在肾素、血管紧张素、醛固酮系统与血压升高密切联系基础之上的血管紧张素转换酶抑制剂（ＡＣＥＩ），以及建立在“钙拮抗机制”理论基础上的钙离子拮抗剂（ＣＡＳ），在心血管疾病的治疗领域占有举足轻重的地位，它的市场运行和临床情况受到广泛的关注。我们对制药公... Established angiotensin-converting enzyme inhibitor (ACEI) based on the close relationship between renin, angiotensin and aldosterone system and high blood pressure, as well as the calcium antagonist based on the theory of “calcium antagonistic mechanism” (CAS ), Occupies a pivotal position in the treatment of cardiovascular diseases, and its market operation and clinical situation have drawn wide attention. We are pharmaceutical companies ...